Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Topakian R, King A, Kwon SU, Schaafsma A, Shipley M, Markus HS; ACES Investigators.
Neurology. 2011; 77(8):751-8.
http://www.ncbi.nlm.nih.gov/pubmed/21849657

Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Markus HS, King A, Shipley M, Topakian R, Cullinane M, Reihill S, Bornstein NM, Schaafsma A.
Lancet Neurol. 2010 Jul;9(7):663-71. Epub 2010 May 31.
http://www.ncbi.nlm.nih.gov/pubmed/20554250

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, Han Z, Tan KS, Ratanakorn D, Chollate P, Zhao Y, Koh A, Hao Q, Markus HS; CLAIR study investigators.
Lancet Neurol. 2010;9(5):489-97.
http://www.ncbi.nlm.nih.gov/pubmed/20335070

Clinical Neuroscience, St. Georges University of London, LoYield of systematic transcranial Doppler in patients with transient ischemic attack. Meseguer E, Lavallée PC, Mazighi M, Labreuche J, Cabrejo L, Olivot JM, Abboud H, Slaoui T, Lapergue B, Guidoux C, Klein IF, Touboul PJ, Amarenco P.
Ann Neurol. 2010;68(1):9-17.
http://www.ncbi.nlm.nih.gov/pubmed/20582954

Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion. Mazumdar M, Heeney MM, Sox CM, Lieu TA.
Pediatrics. 2007;120(4):e1107-16.
http://www.ncbi.nlm.nih.gov/pubmed/17768181

The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. Dittrich R, Ritter MA, Kaps M, Siebler M, Lees K, Larrue V, Nabavi DG, Ringelstein EB, Markus HS, Droste DW.
Stroke. 2006 Apr;37(4):1065-9.
http://www.ncbi.nlm.nih.gov/pubmed/16514091

Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC; CLOTBUST Investigators.
J Neuroimaging. 2004 Apr;14(2):113-7.
http://www.ncbi.nlm.nih.gov/pubmed/15095555

Feasibility and validation of spinal cord vasculature imaging using high resolution ultrasound. Abd Allah F, Majidi S, Watanabe M, Chaudhry SA, Qureshi AI. J Vasc Surg. 2012 Sep;56(3):637-43

http://www.jvascsurg.org/article/S0741-5214%2812%2900386-2/abstract

Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Washington CW, Zipfel GJ; Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage.
Neurocrit Care. 2011 Sep;15(2):312-7.
http://www.ncbi.nlm.nih.gov/pubmed/21748499

Transcranial sonography in movement disorders. Berg D, Godau J, Walter U.
Lancet Neurol. 2008 Nov;7(11):1044-55.
http://www.ncbi.nlm.nih.gov/pubmed/18940694

Clinical experience with transcranial Doppler ultrasonography as a confirmatory test for brain death: a retrospective analysis. Sharma D, Souter MJ, Moore AE, Lam AM.
Neurocrit Care. 2011 14(3):370-6.
http://www.ncbi.nlm.nih.gov/pubmed/20694525

Sonothrombolysis for acute ischemic stroke: a systematic review of randomized controlled trials. Bor-Seng-Shu E, Nogueira Rde C, Figueiredo EG, Evaristo EF, Conforto AB, Teixeira MJ.
Neurosurg Focus. 2012;32(1):E5.
http://www.ncbi.nlm.nih.gov/pubmed/22208898

Brain tumor imaging with transcranial sonography: state of the art and review of the literature. van Leyen K, Klötzsch C, Harrer JU.
Ultraschall Med. 2011;32(6):572-81.
http://www.ncbi.nlm.nih.gov/pubmed/22033868

Ultrasonography of the optic nerve in neurocritically ill patients. Moretti R, Pizzi B.
Acta Anaesthesiol Scand. 2011;55(6):644-52.
http://www.ncbi.nlm.nih.gov/pubmed/21463263

Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes. Berg D.
J Neural Transm. 2011;118(4):613-9.
http://www.ncbi.nlm.nih.gov/pubmed/21207077

Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no. Walter U.
J Neural Transm. 2011 Apr;118(4):607-12.
http://www.ncbi.nlm.nih.gov/pubmed/21190047

Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Aries MJ, Elting JW, De Keyser J, Kremer BP, Vroomen PC.
Stroke. 2010 Nov;41(11):2697-704.
http://www.ncbi.nlm.nih.gov/pubmed/20930158

Current and future recanalization strategies for acute ischemic stroke. Alexandrov AV.
J Intern Med. 2010;267(2):209-19.
http://www.ncbi.nlm.nih.gov/pubmed/20175867